Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ARCT | Arcturus Therapeutics | $9.25 | -$13.92 | -0.60% | 9M | $628.9M | $8.04$24.17 |
| OWLS | Obook | $9.76 | -$9.74 | -0.50% | 654.8K | $1.7B | $9.16$90 |
| ATOM | Atomera | $2.97 | -$1.28 | -0.30% | 2.6M | $133.8M | $2.48$17.55 |
| ATMV | AlphaVest Acquisition Corp | $9.34 | -$4.16 | -0.31% | 124.4K | $52.0M | $8$42 |
| RYOJ | rYojbaba | $6.41 | -$2.71 | -0.30% | 504.4K | $102.6M | $1.81$11.43 |
| GLGG | Themes ETF Trust - Leverage Shares 2x Long Glxy Daily ETF | $28.99 | -$11.79 | -0.29% | 37K | - | $12.38$45.8 |
| OKLL | Tidal Trust II - Defiance Daily Target 2x Long Oklo ETF | $63.97 | -$22.37 | -0.26% | 2.2M | - | $16.09$169.96 |
| SLMT | Brera Holdings PLC | $7.11 | -$2.5 | -26.01% | - | - | - |
| NERV | Minerva Neurosciences | $5 | -$1.41 | -0.22% | 2.7M | $44.8M | $1.15$12.46 |
| QSU | Tidal Trust II | $13.73 | -$4.76 | -25.76% | - | - | - |
Related Articles
Featured Article
Is This Crypto Investment Company Taking on Robinhood?
Patrick Sanders|Oct 8, 2025
The tables are turning on Robinhood.
This Secret AI and Battery Stock Has Soared 148% in Just 5 Weeks
Neha Chamaria|Oct 8, 2025
Investors see SES AI as a potential Trump target. The company, meanwhile, is gearing up for a big event on Oct. 20.
Could Arcturus Therapeutics Be the Next Moderna?
Alex Carchidi|Mar 1, 2022
It's not likely, but it could still end up being a good investment.
Cathie Wood Just Bought Shares of This Vaccine Underdog. Should You?
Adria Cimino|Oct 15, 2021
The company disappointed last year, but things may be turning around.
1 Promising Nasdaq Stock for Cryptocurrency Believers
Kenneth Rapoza|Aug 10, 2021
Bitfarms, an ambitious Canadian Bitcoin miner, will benefit from China's slow exit from the business.
Which Late-to-the-Party COVID Vaccine Stocks Could Still Be Winners?
Keith Speights and Brian Orelli, PhD|Mar 14, 2021
There's at least one biotech that appears to be a potential contender.
Is Arcturus Therapeutics a Buy?
Alex Carchidi|Jan 12, 2021
Only if its COVID-19 vaccine proves to be at least as effective than those developed by its rivals.
Did You Miss Out on the Chance for Big Gains from Arcturus Stock?
Adria Cimino|Jan 6, 2021
The biotech's shares jumped by 299% last year, propelled by optimism about its COVID-19 vaccine candidate.
Why Is Everyone Talking About Arcturus Therapeutics Stock?
Zhiyuan Sun|Jan 5, 2021
This clinical-stage biotech has been a wild ride for investors, and the shifting outlook for its COVID-19 vaccine candidate is the reason why.
Markets Ease Lower as Arcturus, Blink Charging Plunge
Dan Caplinger|Dec 29, 2020
Two top performers fell back to earth on Tuesday.
